Evaluating ATSBs for Malaria Reduction in Kenya
NCT05219565 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2962
Last updated 2024-06-10
Summary
The effectiveness of long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) in western Kenya are threatened by insecticide resistance and vector behaviour changes toward early evening and outdoor biting malaria vectors. New tools to control malaria are needed to reduce and even interrupt malaria transmission. Attractive Targeted Sugar Bait (ATSB) is a promising new intervention designed to attract and kill mosquitoes, including those that IRS and LLINs do not effectively target. The ATSB 'bait stations' are A4-sized panels containing thickened fruit syrup laced with a neonicotinoid insecticide, dinotefuran, to attract and kill the foraging vectors. Entomological field trials in western Mali showed that ATSBs successfully reduce mosquito densities and longevity and thus have the potential to reduce malaria transmission. In Kenya, the investigators will conduct an open-label cluster-randomized controlled trial in 80 village clusters (40 per arm) to evaluate the effect of ATSBs on the burden of malaria. During two years, households in half of these village clusters will receive two or three ATSB bait stations per household structure on exterior walls approximately 1.8 meters above the ground. ATSBs will be replaced every six months. The primary outcome will be the incidence of clinical malaria in children aged 1-\<15 years enrolled in a prospective cohort followed monthly for about six months each during a 2-year period. Secondary outcomes include malaria infection prevalence assessed by rapid diagnostic tests through household surveys and the case burden of clinical malaria assessed by passive facility-based and community-based surveillance. The study includes entomological monitoring and nested acceptability, feasibility, and health economics studies. The stand-alone trial in western Kenya is a part of a multi-country ATSB consortium conducting similar trials in Zambia and Mali.
Conditions
Interventions
- DEVICE
-
Attractive Targeted Sugar Bait (ATSB)
An ATSB is a A4-sized panel containing thickened fruit syrup laced with a neonicotinoid insecticide, dinotefuran. The syrup-insecticide mixture is covered with a protective membrane that allows mosquitoes to feed through the membrane while preventing non-target organisms from feeding. This device is designed to attract and kill mosquitoes.
Sponsors & Collaborators
-
Kenya Medical Research Institute
collaborator OTHER -
Centers for Disease Control and Prevention
collaborator FED -
PATH
collaborator OTHER -
Kenya Ministry of Health
collaborator OTHER_GOV -
Liverpool School of Tropical Medicine
lead OTHER
Principal Investigators
-
Aaron Samuels, MD, MHS · Centers for Disease Control and Prevention
-
Eric Ochomo · Kenya Medical Research Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-03-07
- Primary Completion
- 2024-03-21
- Completion
- 2024-04-24
Countries
- Kenya
Study Locations
More Related Trials
-
Adaptive Interventions for Optimizing Malaria Control: a Cluster-Randomized SMART Trial
NCT04182126 ·Status: COMPLETED ·Phase: NA
-
Restricting the Use of Artesunate Plus Amodiaquine Combination Therapy to Malaria Cases Confirmed by a Dipstick Test: A Cluster Randomised Control Trial
NCT00832754 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children
NCT04167566 ·Status: COMPLETED ·Phase: NA
-
Malaria as a Risk Factor for COVID-19 in Western Kenya and Burkina Faso
NCT04695197 ·Status: COMPLETED ·Phase: PHASE3
-
Spatial Repellents for the Prevention of Malaria in Kenya
NCT04766879 ·Status: COMPLETED ·Phase: NA
-
Impact of Insecticide Resistance on Vector Control
NCT01713517 ·Status: UNKNOWN ·Phase: PHASE4
-
Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya
NCT00336388 ·Status: COMPLETED ·Phase: NA
-
Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister Packs
NCT01065116 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Efficacy Study of AL and DP in Western Kenya
NCT05060198 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Period
NCT01038063 ·Status: UNKNOWN ·Phase: PHASE4
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar
NCT05025761 ·Status: UNKNOWN ·Phase: NA
-
An Extended Follow up of a RTS,S/AS01E Malaria Vaccine Trial
NCT00872963 ·Status: UNKNOWN
-
Efficacy of Amodiaquine-artesunate in Children Aged 6-59 Months With Uncomplicated P. Falciparum Malaria
NCT00425763 ·Status: COMPLETED ·Phase: PHASE4
-
Integrating Malaria Vaccine With Seasonal Malaria Chemoprevention in West Africa
NCT06860178 ·Status: RECRUITING ·Phase: PHASE4
-
Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study
NCT04319380 ·Status: COMPLETED ·Phase: PHASE3
-
Mass Drug Administration of Ivermectin and Dihydroartemisinin-piperaquine as an Additional Intervention for Malaria Elimination
NCT03576313 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Vaccine Efficacy Against Malaria Infection, in Children Immunized With the Primary and Yearly Booster of the RTS,S/AS01E Vaccine, as Part of Their Participation in the Malaria-094 (204889/NCT03276962) Study.
NCT03281291 ·Status: COMPLETED
-
Evaluation of Community-based Mass Screening and Treatment for Malaria in Western Kenya
NCT02987270 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Lao PDR and Cambodia
NCT05117567 ·Status: UNKNOWN ·Phase: NA
-
Effectiveness, Feasibility and Acceptability of Seasonal Malaria Chemoprevention in Aweil South County in South Sudan
NCT05471544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ)
NCT03143218 ·Status: COMPLETED ·Phase: PHASE3
-
Malaria Therapeutic Efficacy Study (TES) Kenya
NCT04767191 ·Status: COMPLETED ·Phase: PHASE4
-
Randomised Efficacy Study of Two Artemether-Lumefantrine Oral Formulations for the Treatment of Uncomplicated P. Falciparum Malaria
NCT00529867 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study
NCT02511353 ·Status: COMPLETED ·Phase: PHASE2
-
Malaria High-Risk Populations in Namibia
NCT04094727 ·Status: COMPLETED ·Phase: PHASE4